0,853  0,003  Antimutagenic
0,841  0,003  Genotoxic
0,829  0,007  Caspase 9 stimulant
0,720  0,005  Cardiovascular analeptic
0,710  0,007  12-Lipoxygenase inhibitor
0,707  0,008  CYP1A2 substrate
0,694  0,006  NOS2 expression inhibitor
0,716  0,028  Apoptosis agonist
0,688  0,011  Respiratory analeptic
0,678  0,005  Superoxide dismutase inhibitor
0,680  0,014  CYP2C9 substrate
0,680  0,023  Transcription factor NF kappa B inhibitor
0,648  0,009  CYP2D6 substrate
0,640  0,005  Antiseptic
0,633  0,004  Sulfotransferase substrate
0,634  0,008  Caspase 3 stimulant
0,624  0,003  UGT2B4 substrate
0,639  0,019  15-Lipoxygenase inhibitor
0,626  0,006  Cardiodepressant
0,628  0,009  Antioxidant
0,638  0,019  GST A substrate
0,621  0,005  FMO1 substrate
0,655  0,040  Antiinflammatory
0,633  0,020  TNF expression inhibitor
0,614  0,006  UGT1A4 substrate
0,614  0,006  UGT1A1 substrate
0,610  0,008  Free radical scavenger
0,614  0,014  Sensitization
0,596  0,004  UGT1A3 substrate
0,605  0,014  Radioprotector
0,600  0,010  Lipoxygenase inhibitor
0,608  0,029  Antineoplastic (lung cancer)
0,593  0,015  5 Hydroxytryptamine release stimulant
0,588  0,015  CYP2C19 substrate
0,576  0,009  UGT1A6 substrate
0,573  0,012  Antineoplastic (non-small cell lung cancer)
0,576  0,015  Analeptic
0,560  0,005  Anesthetic general
0,567  0,018  Chemoprotective
0,561  0,016  CTGF expression inhibitor
0,557  0,014  AR expression inhibitor
0,561  0,024  Aldehyde oxidase inhibitor
0,536  0,004  UGT2B15 substrate
0,565  0,041  Antineoplastic (breast cancer)
0,526  0,006  Melanin inhibitor
0,523  0,004  Pneumotoxic
0,530  0,013  Antipyretic
0,518  0,004  5 Hydroxytryptamine uptake stimulant
0,530  0,017  UGT1A9 substrate
0,531  0,020  Antineoplastic (melanoma)
0,509  0,004  GST P1-1 substrate
0,507  0,005  FMO3 substrate
0,514  0,018  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,530  0,034  Antileukemic
0,511  0,018  Chemopreventive
0,492  0,005  Carcinogenic, group 2B
0,504  0,023  Carcinogenic
0,503  0,026  Antihypercholesterolemic
0,488  0,013  Antihypertriglyceridemic
0,506  0,032  Cholesterol antagonist
0,481  0,008  Skin whitener
0,502  0,040  CYP3A4 substrate
0,449  0,001  UGT2B10 substrate
0,473  0,026  Cardioprotectant
0,454  0,009  Tubulin antagonist
0,445  0,003  Vanilloid 1 agonist
0,472  0,030  Ulceration
0,472  0,032  CYP2C19 inhibitor
0,450  0,009  Monophenol monooxygenase inhibitor
0,452  0,014  Skin irritative effect
0,507  0,079  Alpha-glucosidase inhibitor
0,461  0,039  Prostate cancer treatment
0,441  0,021  Nitric oxide antagonist
0,440  0,024  Proliferative diseases treatment
0,454  0,040  GABA C receptor rho-3 antagonist
0,434  0,020  Amyloid beta aggregation inhibitor
0,430  0,017  UDP-glucuronosyltransferase substrate
0,455  0,043  Antineoplastic (colorectal cancer)
0,418  0,006  Tyrosine 3 hydroxylase inhibitor
0,444  0,032  Spasmolytic
0,456  0,045  Immunosuppressant
0,423  0,013  Flavin-containing monooxygenase substrate
0,435  0,026  Antineoplastic (multiple myeloma)
0,415  0,010  Antihypotensive
0,446  0,042  Antineoplastic (colon cancer)
0,433  0,030  Antineoplastic (glioma)
0,431  0,029  Cytostatic
0,452  0,049  Histamine release inhibitor
0,409  0,008  NOS3 expression enhancer
0,426  0,026  Antiprotozoal (Leishmania)
0,415  0,025  Antineoplastic (glioblastoma multiforme)
0,416  0,026  Hypoxia-inducible factor 1 alpha inhibitor
0,426  0,039  Antineoplastic (ovarian cancer)
0,421  0,034  Antineoplastic (brain cancer)
0,413  0,028  CYP1A2 inhibitor
0,410  0,025  Tumour necrosis factor alpha release inhibitor
0,391  0,010  VCAM1 expression inhibitor
0,407  0,029  Mutagenic
0,403  0,026  Antineoplastic (lymphoma)
0,427  0,056  Antipruritic, allergic
0,406  0,035  Antineoplastic (cervical cancer)
0,384  0,021  Sedative
0,390  0,028  Calcium channel activator
0,401  0,044  Teratogen
0,381  0,029  Antihypoxic
0,403  0,052  Angiogenesis inhibitor
0,362  0,012  Amylase inhibitor
0,389  0,039  Vasodilator, coronary
0,397  0,050  Antithrombotic
0,384  0,038  Cytotoxic
0,359  0,014  Carcinogenic, group 3
0,386  0,041  Antineoplastic (pancreatic cancer)
0,400  0,055  Vasodilator, peripheral
0,364  0,019  GST M1-1 substrate
0,350  0,009  Neurotrophic factor enhancer
0,384  0,044  Embryotoxic
0,354  0,017  UGT2B7 substrate
0,364  0,028  Antineoplastic (endocrine cancer)
0,341  0,006  Succinate dehydrogenase inhibitor
0,339  0,004  Vanilloid agonist
0,341  0,007  UGT2B9 substrate
0,365  0,032  Antineoplastic (renal cancer)
0,362  0,030  Antimitotic
0,361  0,030  Pyruvate kinase inhibitor
0,376  0,045  NOS3 expression inhibitor
0,355  0,027  Peroxidase inhibitor
0,376  0,050  ICAM1 expression inhibitor
0,347  0,023  Muscle relaxant
0,357  0,034  Antineoplastic (osteosarcoma)
0,335  0,016  DNA methyltransferase I inhibitor
0,330  0,012  CYP2B6 inhibitor
0,324  0,007  UGT2B1 substrate
0,344  0,031  Sigma receptor agonist
0,325  0,016  Lipid peroxidase inhibitor
0,317  0,009  Carcinogenic, group 1
0,343  0,035  Vasodilator
0,327  0,021  DNA methylase inhibitor
0,316  0,009  5-Lipoxygenase inhibitor
0,356  0,053  Apoptosis antagonist
0,316  0,021  5 Hydroxytryptamine 1E antagonist
0,301  0,008  LDLR expression enhancer
0,311  0,019  Skeletal muscle relaxant
0,333  0,042  Hypoglycemic
0,325  0,035  Antiulcerative
0,363  0,074  CYP2C9 inhibitor
0,320  0,031  Abortion inducer
0,328  0,040  Antineoplastic (liver cancer)
0,375  0,088  Antibacterial
0,304  0,018  Protein-tyrosine phosphatase inhibitor
0,292  0,009  Expectorant
0,302  0,020  Interferon gamma antagonist
0,325  0,046  Radiosensitizer
0,297  0,018  Tumour necrosis factor antagonist
0,305  0,027  Non-steroidal antiinflammatory agent
0,288  0,011  Cystathionine beta-synthase inhibitor
0,322  0,046  Antiamyloidogenic
0,281  0,007  Cyclooxygenase 3 inhibitor
0,321  0,047  Insulysin inhibitor
0,284  0,011  SULT1A3 substrate
0,309  0,038  Antineoplastic (sarcoma)
0,329  0,061  CYP3A4 inhibitor
0,289  0,022  Anesthetic
0,307  0,041  Antiparasitic
0,271  0,005  TRPA1 agonist
0,312  0,048  Transcription factor STAT3 inhibitor
0,266  0,007  Toll-Like receptor 2 antagonist
0,270  0,014  Protein-tyrosine phosphatase 1B inhibitor
0,310  0,053  Antiprotozoal (Trypanosoma)
0,287  0,030  Eye irritation, high
0,273  0,016  Glutathione S-transferase substrate
0,260  0,005  Mucolytic
0,324  0,070  Antifungal
0,260  0,011  Neurotrophic factor
0,274  0,025  Antineoplastic (carcinoma)
0,292  0,045  Psychostimulant
0,324  0,079  Antiallergic
0,250  0,004  Adenylate cyclase stimulant
0,273  0,028  Antipruritic, non-allergic
0,249  0,005  Beta tubulin antagonist
0,260  0,016  Cholesterol synthesis inhibitor
0,283  0,039  Platelet adhesion inhibitor
0,245  0,002  UGT2B11 substrate
0,259  0,018  Anesthetic local
0,248  0,010  SULT1A1 substrate
0,351  0,114  5 Hydroxytryptamine release inhibitor
0,248  0,012  Xanthine oxidase inhibitor
0,273  0,037  Hepatoprotectant
0,260  0,026  Nitric-oxide synthase stimulant
0,313  0,080  Bone diseases treatment
0,252  0,021  MAO A inhibitor
0,260  0,029  Insulin sensitizer
0,250  0,020  Aldehyde oxidase substrate
0,241  0,014  GABA C receptor rho-2 antagonist
0,247  0,021  Alkaline phosphatase inhibitor
0,288  0,062  DNA damaging
0,266  0,040  Antihelmintic
0,251  0,026  Protein kinase stimulant
0,254  0,030  Antineoplastic (squamous cell carcinoma)
0,318  0,094  Prostaglandin dehydrogenase inhibitor
0,231  0,008  Phosphodiesterase 4D inhibitor
0,276  0,053  Antineoplastic (lymphocytic leukemia)
0,233  0,011  Breast cancer-resistant protein inhibitor
0,233  0,011  Choleretic
0,259  0,039  P-glycoprotein inhibitor
0,237  0,020  Antifungal enhancer
0,222  0,007  Papain-like protease (SARS coronavirus) inhibitor
0,238  0,024  NADPH oxidase inhibitor
0,226  0,015  Microtubule formation inhibitor
0,279  0,068  Transcription factor STAT inhibitor
0,258  0,048  ErbB-1 antagonist
0,231  0,025  Cyclooxygenase 1 inhibitor
0,266  0,062  Antiglaucomic
0,212  0,009  HIV-1 integrase (Overall Integration) inhibitor
0,229  0,030  Phospholipase C inhibitor
0,314  0,114  Antiprotozoal
0,216  0,020  Arachidonic acid antagonist
0,202  0,006  Alpha tubulin antagonist
0,339  0,143  DNA directed DNA polymerase inhibitor
0,208  0,013  Carbonic anhydrase XIII inhibitor
0,230  0,036  Antineoplastic (gastric cancer)
0,218  0,025  ATPase inhibitor
0,240  0,047  Antiviral (West Nile virus)
0,210  0,020  Interleukin 4 antagonist
0,235  0,046  I kappa B kinase epsilon inhibitor
0,198  0,010  Carcinogenic, group 2A
0,268  0,081  Antiosteoporotic
0,214  0,029  M18 aspartyl aminopeptidase inhibitor
0,220  0,035  MAO inhibitor
0,283  0,098  Antineoplastic (small cell lung cancer)
0,193  0,009  Electron transport complex I inhibitor
0,204  0,020  Antihemorrhagic
0,281  0,097  Sodium/bile acid cotransporter inhibitor
0,198  0,016  Coagulant
0,190  0,008  Heat shock protein 70 antagonist
0,264  0,083  Lipoprotein disorders treatment
0,231  0,052  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,215  0,037  VEGF expression inhibitor
0,243  0,067  Cyclic AMP phosphodiesterase inhibitor
0,198  0,023  CF transmembrane conductance regulator agonist
0,206  0,032  Neurotensin receptor agonist
0,236  0,062  Peptidyltransferase inhibitor
0,326  0,151  DNA polymerase beta inhibitor
0,180  0,006  Antifungal (Pneumocystis)
0,197  0,024  Alpha 2b adrenoreceptor antagonist
0,206  0,034  Uterine stimulant
0,179  0,010  DOPA decarboxylase inhibitor
0,313  0,146  Calcium channel L-type activator
0,239  0,075  Angiogenesis stimulant
0,311  0,148  Transcription factor inhibitor
0,174  0,014  Prolactin inhibitor
0,226  0,068  RNA-directed DNA polymerase inhibitor
0,177  0,019  Gastritis treatment
0,168  0,011  Macrophage migration inhibitory factor inhibitor
0,174  0,018  Antispirochetal
0,166  0,010  Glutamate decarboxylase inhibitor
0,161  0,006  GABA aminotransferase inhibitor
0,172  0,020  Aldehyde dehydrogenase substrate
0,196  0,043  Antineoplastic (bone cancer)
0,172  0,021  Contraceptive female
0,160  0,010  Phenylalanine 4-hydroxylase inhibitor
0,227  0,079  Hypolipemic
0,161  0,014  Transcription factor NF kappa B stimulant
0,159  0,012  Antiviral (Coronavirus)
0,159  0,012  Antiviral (SARS coronavirus)
0,165  0,019  Estrogen antagonist
0,155  0,009  Prostaglandin EP2 antagonist
0,170  0,025  Alpha 2c adrenoreceptor antagonist
0,234  0,091  Interleukin agonist
0,291  0,148  Antiparkinsonian
0,175  0,034  Antieczematic
0,154  0,014  Keratolytic
0,158  0,021  Sphingomyelinase inhibitor
0,313  0,176  Antineoplastic (solid tumors)
0,141  0,005  Endocannabinoid uptake inhibitor
0,184  0,048  Antidote
0,141  0,005  Leukotriene B4 antagonist
0,160  0,025  Mediator release inhibitor
0,161  0,028  Alcohol dehydrogenase substrate
0,163  0,032  Chelator
0,152  0,022  Phosphodiesterase IV inhibitor
0,150  0,021  Toll-Like receptor 4 antagonist
0,145  0,017  Estrogen receptor beta antagonist
0,150  0,023  Urease inhibitor
0,139  0,012  Antifungal (Aspergillus)
0,185  0,058  Antirickettsial
0,185  0,058  Antihelmintic (Nematodes)
0,180  0,054  Phospholipase A2 inhibitor
0,148  0,022  GABA C receptor rho-1 antagonist
0,133  0,008  Beta 3 adrenoreceptor antagonist
0,153  0,027  Carbonic anhydrase III inhibitor
0,146  0,022  Carbonic anhydrase VI inhibitor
0,142  0,018  Inducible nitric-oxide synthase inhibitor
0,136  0,014  Estrogen receptor alpha antagonist
0,130  0,009  Narcotic antagonist
0,130  0,008  Beta adrenoreceptor antagonist
0,142  0,021  Histidine decarboxylase inhibitor
0,151  0,030  Carbonic anhydrase XV inhibitor
0,150  0,030  GABA C receptor antagonist
0,135  0,016  Glutathione S-transferase inhibitor
0,146  0,027  Beta glucuronidase inhibitor
0,173  0,054  Heat shock protein 90 antagonist
0,143  0,024  Topoisomerase II alpha inhibitor
0,141  0,023  Anabolic
0,134  0,017  Ornithine decarboxylase inhibitor
0,148  0,032  Bronchodilator
0,152  0,038  Ca2+-transporting ATPase inhibitor
0,157  0,043  Epidermal growth factor receptor kinase inhibitor
0,127  0,014  Leukotriene antagonist
0,125  0,013  Granulocyte macrophage colony stimulating factor agonist
0,121  0,010  Estrogen-related receptor beta agonist
0,145  0,034  Photosensitizer
0,127  0,017  HIV-1 integrase (3'-Processing) inhibitor
0,116  0,006  Potassium channel Kv1.3 blocker
0,122  0,013  SULT1A2 substrate
0,150  0,041  Beta amyloid protein antagonist
0,125  0,016  Bile acid receptor antagonist
0,197  0,089  Antineoplastic enhancer
0,123  0,015  Leukotriene synthesis inhibitor
0,189  0,083  Septic shock treatment
0,161  0,056  Hemostatic
0,216  0,111  Immunostimulant
0,156  0,051  Antifungal (Cryptococcus)
0,150  0,046  Antibacterial (Helicobacter pylori)
0,164  0,060  Cyclooxygenase inhibitor
0,189  0,086  Histone acetyltransferase inhibitor
0,144  0,041  Antineoplastic (uterine cancer)
0,134  0,034  Dementia treatment
0,104  0,004  Melatonin 2 agonist
0,104  0,005  Vanilloid 2 antagonist
0,151  0,054  Acetylcholinesterase inhibitor
0,121  0,025  Adrenaline agonist
0,115  0,019  Aromatase inhibitor
0,213  0,117  Antineoplastic (bladder cancer)
0,114  0,018  HIV-1 integrase (Strand Transfer) inhibitor
0,128  0,033  Vascular dementia treatment
0,167  0,072  Heat shock protein 90 alpha antagonist
0,157  0,064  Hair growth stimulant
0,101  0,009  Exportin-1 inhibitor
0,100  0,008  Sphingosine kinase 2 inhibitor
0,147  0,055  Cocaine dependence treatment
0,098  0,006  Glucose-6-phosphate translocase inhibitor
0,101  0,010  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,139  0,048  Interleukin 1b antagonist
0,097  0,007  Postcoital contraceptive
0,170  0,081  Amyloid beta precursor protein antagonist
0,143  0,054  Antihelmintic (Trematoda)
0,178  0,089  Antiviral (Influenza)
0,096  0,008  Transcription factor RelA inhibitor
0,111  0,023  CDC25A inhibitor
0,156  0,069  Insulin secretagoues
0,121  0,034  Arylamine N-Acetyltransferase substrate
0,198  0,111  Vascular (periferal) disease treatment
0,097  0,011  Beta 1 adrenoreceptor antagonist
0,090  0,005  Ryanodine receptor antagonist
0,138  0,053  Adenylate cyclase inhibitor
0,137  0,052  Antiprotozoal (Amoeba)
0,121  0,036  Alpha 2 adrenoreceptor antagonist
0,130  0,046  MAO B inhibitor
0,095  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,114  0,031  Alpha 2a adrenoreceptor antagonist
0,090  0,007  Squalene synthetase inhibitor
0,138  0,056  DNA polymerase I inhibitor
0,110  0,028  ATPase (Vacuolar H+) inhibitor
0,097  0,015  Alpha 2 adrenoreceptor agonist
0,105  0,024  Dopamine D1 antagonist
0,127  0,045  GABA C receptor agonist
0,155  0,074  Antiviral (Herpes)
0,148  0,068  Antianemic
0,086  0,005  Dopamine D5 agonist
0,090  0,009  Beta 2 adrenoreceptor antagonist
0,187  0,106  Antiviral (HIV)
0,112  0,032  NAD(P)H dehydrogenase (quinone) inhibitor
0,143  0,064  Bone formation stimulant
0,088  0,009  Calcium channel P-type blocker
0,115  0,036  Androgen antagonist
0,138  0,059  Sphingosine 1-phosphate receptor 2 antagonist
0,085  0,006  Adenylate cyclase 1 inhibitor
0,093  0,015  Antimycoplasmal
0,137  0,060  Antihyperlipoproteinemic
0,082  0,005  Dopamine beta hydroxylase inhibitor
0,158  0,082  Mcl-1 antagonist
0,157  0,082  Growth hormone agonist
0,109  0,035  Alpha 2d adrenoreceptor antagonist
0,148  0,074  Antidiarrheal
0,079  0,005  Catechol O-methyltransferase inhibitor
0,132  0,057  Proteasome inhibitor
0,079  0,005  Melatonin agonist
0,095  0,021  GABA B receptor agonist
0,106  0,032  Tocolytic
0,093  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,148  0,075  Movement disorders treatment
0,119  0,046  Antiprotozoal (Toxoplasma)
0,097  0,025  Ca(v)3.1 blocker
0,146  0,074  Acaricide
0,079  0,007  Factor III inhibitor
0,090  0,019  Xanthine dehydrogenase inhibitor
0,109  0,039  Thioredoxin inhibitor
0,119  0,049  Acetylcholine release stimulant
0,097  0,027  HIV-1 integrase inhibitor
0,098  0,028  Lipase inhibitor
0,089  0,020  Neuraminidase inhibitor
0,157  0,087  Dual specificity phosphatase inhibitor
0,080  0,011  Dihydroorotate oxidase inhibitor
0,087  0,018  SULT2A1 substrate
0,146  0,078  Cytidine deaminase inhibitor
0,145  0,078  Antiviral (Influenza A)
0,121  0,055  Topoisomerase I inhibitor
0,092  0,026  Glycine receptor agonist
0,094  0,028  Carbonic anhydrase VA inhibitor
0,106  0,041  Phosphodiesterase 6D inhibitor
0,095  0,030  Alpha adrenoreceptor agonist
0,074  0,010  Pregnane X receptor antagonist
0,159  0,096  Phobic disorders treatment
0,096  0,033  Phosphofructokinase-1 inhibitor
0,092  0,030  Carbonic anhydrase V inhibitor
0,109  0,047  Nitric-oxide synthase inhibitor
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,078  0,018  Sphingosine kinase inhibitor
0,082  0,022  Estrogen agonist
0,137  0,077  Mannose-6-phosphate isomerase inhibitor
0,072  0,013  Lysophosphatidic acid 3 receptor antagonist
0,123  0,064  Topoisomerase II inhibitor
0,107  0,048  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,088  0,029  MAP kinase kinase 7 inhibitor
0,224  0,166  Antiprotozoal (Plasmodium)
0,095  0,037  Glycine receptor antagonist
0,071  0,014  Anesthetic inhalation
0,133  0,077  Farnesoid X receptor antagonist
0,119  0,063  Shock treatment
0,077  0,021  Fatty acid synthase inhibitor
0,107  0,052  Creatine kinase inhibitor
0,070  0,016  Estrogen receptor beta agonist
0,093  0,040  CYP2A6 inhibitor
0,108  0,055  Chronic obstructive bronchitis treatment
0,171  0,118  Antialcoholic
0,079  0,026  Neuraminidase (influenza) inhibitor
0,085  0,033  Phosphodiesterase 4B inhibitor
0,080  0,028  CDC25B inhibitor
0,059  0,007  Melatonin 1 agonist
0,099  0,048  Calcium antagonist
0,063  0,013  Retinoid X receptor agonist
0,133  0,083  Antianorexic
0,093  0,044  Myeloperoxidase inhibitor
0,074  0,025  Postmenopausal disorders treatment
0,119  0,071  Aldehyde dehydrogenase inhibitor
0,194  0,147  Antiischemic
0,056  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,058  0,011  Dihydrofolate reductase inhibitor
0,072  0,026  Carbonic anhydrase VB inhibitor
0,204  0,159  Thyroid hormone antagonist
0,053  0,008  Lysophosphatidic acid 2 receptor antagonist
0,196  0,152  CYP2D6 inhibitor
0,054  0,010  Kainate receptor agonist
0,088  0,044  Thioredoxin reductase inhibitor
0,122  0,078  Cyclooxygenase 2 inhibitor
0,056  0,012  Retinoid X alpha receptor agonist
0,104  0,061  Adenylate kinase inhibitor
0,105  0,063  GST T1-1 substrate
0,120  0,078  Alpha-N-acetylglucosaminidase inhibitor
0,086  0,044  Nicotinic alpha4beta2 receptor antagonist
0,093  0,051  Epidermal growth factor antagonist
0,054  0,013  Inosine monophosphate dehydrogenase inhibitor
0,055  0,013  TRPM8 blocker
0,049  0,008  Leukotriene B4 receptor 1 antagonist
0,116  0,075  Antiviral (Influenza B)
0,057  0,016  Estrogen receptor alpha agonist
0,107  0,066  Antihelmintic (Fasciola)
0,094  0,054  Triose-phosphate isomerase inhibitor
0,048  0,009  Melatonin receptor 1A agonist
0,111  0,072  Antitussive
0,068  0,029  Fibroblast growth factor 4 antagonist
0,092  0,054  Antidote, mercury
0,099  0,062  Butyrylcholinesterase inhibitor
0,066  0,029  Beta 2 adrenoreceptor agonist
0,087  0,050  D-Ala-D-Ala ligase inhibitor
0,087  0,050  Antiprotozoal activity enhancer
0,105  0,069  Multidrug resistance-associated protein 1 inhibitor
0,071  0,035  5 Hydroxytryptamine 2A agonist
0,049  0,014  Vesicle monoamine transporter inhibitor
0,069  0,034  Antidote, heavy metal
0,081  0,047  Porphobilinogen synthase inhibitor
0,061  0,027  Leukotriene C antagonist
0,149  0,115  Toxic, respiratory center
0,180  0,146  Streptokinase A inhibitor
0,059  0,025  Carbonic anhydrase XIV inhibitor
0,040  0,009  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,078  0,047  Antitreponemal
0,077  0,046  Phosphodiesterase VI inhibitor
0,045  0,014  Vanilloid 3 antagonist
0,054  0,024  Carbonic anhydrase VII inhibitor
0,074  0,044  Amidase inhibitor
0,063  0,037  Androgen agonist
0,085  0,059  Antineoplastic alkaloid
0,046  0,020  Dihydropteroate synthase inhibitor
0,190  0,164  Thyroid hormone beta antagonist
0,098  0,072  Falcipain 3 inhibitor
0,094  0,069  Antifungal (Candida)
0,097  0,072  Gout treatment
0,073  0,048  Calcium channel L-type blocker
0,045  0,021  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,089  0,065  SULT1E1 substrate
0,042  0,018  Phosphoglycerate kinase inhibitor
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,069  0,048  Elastase 1 inhibitor
0,037  0,016  GABA transporter 3 inhibitor
0,035  0,014  Uridine phosphorylase inhibitor
0,026  0,005  Alpha 2b adrenoreceptor agonist
0,029  0,009  Dopamine D1 agonist
0,251  0,232  MAP kinase 1 inhibitor
0,038  0,018  Sodium-dependent vitamin C transporter 2 inhibitor
0,103  0,084  Cell adhesion inhibitor
0,040  0,022  Glutamate (mGluR8) agonist
0,091  0,073  UDP-glucose 4-epimerase inhibitor
0,084  0,066  NADH dehydrogenase inhibitor
0,079  0,062  ErbB-3 antagonist
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,040  0,024  Diamine oxidase inhibitor
0,034  0,019  ATP citrate lysase inhibitor
0,045  0,030  Beta adrenoreceptor agonist
0,025  0,010  Inosine monophosphate dehydrogenase 2 inhibitor
0,059  0,044  Purinergic P2X1 antagonist
0,035  0,021  Peroxisome proliferator-activated receptor delta agonist
0,049  0,035  Squalene epoxidase inhibitor
0,075  0,061  Antineoplastic antibiotic
0,093  0,080  AMP-activated protein kinase stimulant
0,069  0,057  Antibiotic
0,069  0,057  Glutamate dehydrogenase inhibitor
0,043  0,031  Heme oxygenase inhibitor
0,123  0,111  Thiol protease inhibitor
0,040  0,029  Liver X receptor alpha agonist
0,051  0,041  Nicotinic alpha3beta2 receptor antagonist
0,066  0,056  Anticholelithogenic
0,112  0,102  Interleukin 1 antagonist
0,057  0,048  TRPA1 antagonist
0,038  0,029  Leukotriene C4 antagonist
0,023  0,014  Prostaglandin F2 alpha agonist
0,036  0,027  5-Alpha-reductase inhibitor
0,119  0,111  Thrombolytic
0,092  0,084  Excitatory amino acid transporter EAAC1 inhibitor
0,039  0,030  VCAM-1 antagonist
0,064  0,055  Glutamate (mGluR7) antagonist
0,109  0,101  Antiviral (Papilloma)
0,038  0,030  VCAM antagonist
0,088  0,081  Gastric antisecretory
0,025  0,019  Sodium/glucose cotransporter inhibitor
0,020  0,014  Imidazoline I1 receptor antagonist
0,065  0,060  Cathepsin G inhibitor
0,099  0,093  Caspase 3 inhibitor
0,019  0,013  Alpha 2c adrenoreceptor agonist
0,025  0,021  Nicotinic acid receptor 2 antagonist
0,019  0,014  Antibiotic Anthracycline-like
0,033  0,029  Adenosine uptake inhibitor
0,100  0,096  Myasthenia Gravis treatment
0,017  0,013  Antibiotic Trimethoprim-like
0,044  0,041  Glucose-6-phosphate isomerase inhibitor
0,029  0,027  Nucleoside transporters inhibitor
0,060  0,058  Peroxisome proliferator-activated receptor gamma agonist
0,057  0,055  Hyperparathyroidism treatment
0,066  0,064  Peroxisome proliferator-activated receptor gamma antagonist
0,030  0,029  Glutamate (mGluR3) agonist
0,102  0,102  Contraceptive
0,030  0,030  Estrogen-related receptor beta antagonist
0,030  0,029  Progesterone antagonist

